Article
Doxorubicin Drives Chemoresistance in Osteosarcoma by Inducing Adaptive Plasticity and IL-1β/COX-2-mediated Inflammation
2026-08-07
Abstract excerpt
<title>Abstract</title> <p>Osteosarcoma is the most frequent bone malignancy in children and adolescents. Unfortunately, despite advances in treatment, chemoresistance and tumour recurrence remain major challenging obstacles. Increasing evidence suggests that surviving malignant cells can undergo adaptive reprogramming following chemotherapy, attaining cancer stem cell (CSC)-associated characteristics and other c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 934b9033-af0a-5b92-809e-2f8e06724494
- DOI
- 10.21203/rs.3.rs-10122129/v1
